Skip to content
Onyx Platform

Zimbabwe Turns Down ‘Lopsided’ US Health Aid Deal Because of Data Concerns

Medical aid image
The proposed US funding would have supported programmes for HIV/Aids treatment and prevention, tuberculosis, and malaria.

The nation of Zimbabwe has turned down a substantial American health deal worth 367 million US dollars (272 million pounds) over five years because of Washington's request for confidential biological samples.

This move came to light after a official document from December was disclosed, indicating that Head of State Emmerson Mnangagwa deemed the agreement was "skewed".

A government spokesman later clarified that the US was demanding access to biological samples for research and profit while was not willing to guarantee the resulting advantages from any future treatments.

"We are forced to start the difficult and regrettable process of winding down our health assistance in Zimbabwe," stated American envoy to Zimbabwe Pamela Tremont in a statement.

Her embassy indicated the United States had provided over $1.9bn in health funding to Zimbabwe during the past two decades.

A medical body in Zimbabwe has appealed for more talks to secure a deal agreeable to all parties so the nation's critical HIV treatment initiative can proceed.

Wider Implications

This rejection comes after a comparable case in neighbouring Kenya, where a high court suspended a related deal with the US following legal challenges were raised about the safety of citizens' health data.

Since resuming office recently, US President Donald Trump has drastically cut foreign aid and shut down the key foreign aid agency.

USAID had administered assistance for the American government, but Trump argued its spending was "inefficient" and his administration was pursuing government-to-government deals to boost openness and accountability.

As per reports, 16 African countries have so far signed these new health pacts, constituting over $18.3bn in new funding.

Specifics of the Declined Agreement

This assistance for Zimbabwe would have gone towards "combating HIV/Aids, tuberculosis, malaria, maternal and child health, and disease outbreak preparedness.

"We are confident this collaboration could have provided significant benefits for the people of Zimbabwe, especially the 1.2 million presently on antiretroviral therapy via US-supported initiatives," Tremont said.

However, official spokesman Nick Mangwana said the arrangement was "unequal".

"The proposal required Zimbabwe to surrender its biological resources and data for a long time, with no corresponding assurance of benefiting from any medical innovations – like vaccines, diagnostics, or treatments – that might result from that provided information," he stated.

"Effectively, our country would supply the basic resources for medical research without any assurance that the end products would be available to our citizens if a new health crisis emerge."

Sovereignty and Global Health

He also pointed out that the American exit from the global health body and its push of one-on-one health agreements were undermining structures previously set up via the global organization.

Mangwana cited its Pandemic Benefit-Sharing system designed to deal with future global health emergencies.

"This system is intended to guarantee that when a country contributes its data, the resulting advantages – including vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to develop them."

The government's concerns regarding the US deal "are not meant as opposition to America," Mangwana stressed.

"We encourage further dialogue with our US partners on how subsequent co-operation might be arranged in a way that respects the sovereignty and dignity of both nations."

Medical Community Reaction

A leading public health body stated it acknowledged the official position, but urged that talks must proceed since much of the country's HIV programmes were funded by external financing.

"If specific concerns arise, such as those involving data governance or agreement terms, these can frequently be resolved via detailed discussion and negotiated safeguards," it commented.

The halted deal underscores the continuing challenges between receiving vital international aid and protecting a country's data in an ever more interconnected world.

LB
By

Lisa Bailey

A software engineer and tech writer with over a decade of experience in cloud computing and AI, passionate about demystifying complex technologies for developers.

Onyx Platform

Type to search articles.